We also observed that renal inflammation, as measured by infiltration of CD3+ lymphocytes and CD45+ leukocytes as well as expression levels of pro-inflammatory mediators in the kidneys, was significantly dampened by quisinostat administration (Supplementary Figure S3). The gene discussed is PTPRC; the disease is inflammation.